Tao Wang
Postdoctoral Research Fellow
PhD
tao.wang@thekids.org.au
Dr Wang is an emerging leader in the field of nucleic acid (DNA/RNA) chemistry and anti-cancer drug development, with 49 publications and over 2,300 citations since he received his PhD degree in 2015.
His research in functional nucleic acid research attracted wide media coverage locally and nationally (ABC News & The West Australian). Recently, he was awarded the 2022 Raine priming grant.
Find Dr Wang on ORCID.
Projects
What is triggering immune reactions in people with MS?
Multiple sclerosis (MS) is a condition where a person's immune system attacks the brain and spinal cord.
Published research
Role of COL5A1 in lung squamous cell Carcinoma: Prognostic Implications and therapeutic potential
Lung squamous cell carcinoma (LUSC) is a significant health concern, characterized by a lack of specific therapies and limited treatment options for patients in advanced stages. This study aims to identify key molecules of prognostic importance in LUSC and provide an experimental foundation for their potential therapeutic applications.
Use of high-resolution fluorescence in situ hybridization for fast and robust detection of SARS-CoV-2 RNAs
Early, rapid, and accurate diagnostic tests play critical roles not only in the identification/management of individuals infected by SARS-CoV-2, but also in fast and effective public health surveillance, containment, and response. Our aim has been to develop a fast and robust fluorescence in situ hybridization (FISH) detection method for detecting SARS-CoV-2 RNAs by using an HEK 293 T cell culture model.
Local therapy with combination TLR agonists stimulates systemic anti-tumor immunity and sensitizes tumors to immune checkpoint blockade
Protocol for delivery of intraoperative immunotherapy to mice by surgical debulking of subcutaneous tumors
Pre-clinical studies developing novel therapies to prevent cancer recurrence require appropriate surgical models. Here, we present a protocol for surgical debulking of subcutaneous tumors in mice, which allows for intraoperative application of immunotherapy-loaded biomaterials.
Supportive care needs and associated factors among caregivers of patients with colorectal cancer: a cross-sectional study
To assess the level of supportive care needs of caregivers of colorectal cancer patients and explore the related key influencing factors. Totaling 283 caregivers of patients with colorectal cancer were investigated in this study.
Post-surgery financial toxicity and its influencing factors in colorectal cancer care: A cross-sectional study
This study aimed to investigate the influence factors of financial toxicity experienced by colorectal cancer patients after surgery. The results will provide deep insights for developing effective intervention strategies to address this common issue of colorectal cancer care.
Caregiver burden, mutuality, and family resilience in colorectal cancer caring: A mediating model analysis
This study investigates the interaction between caregiver burden, mutuality, and family resilience in colorectal cancer management, and determines whether mutuality affects the effect of caregiver burden on family resilience.
A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC.
Glutamine Deprivation Synergizes the Anticancer Effects of Cold Atmospheric Plasma on Esophageal Cancer Cells
Esophageal cancer is a highly aggressive malignancy with a low response to standard anti-cancer therapies. There is an unmet need to develop new therapeutic strategies to improve the clinical outcomes of current treatments. Cold atmospheric plasma (CAP) is a promising approach for cancer treatment, and has displayed anticancer efficacy in multiple preclinical models. Recent studies have shown that the efficacy of CAP is positively correlated with intracellular reactive oxygen species (ROS) levels.
Education and Qualifications
- May 2011 - March 2015 - PhD in Biomedicine, Deakin University, Australia
- Sep. 2002 - July 2005 - Master's in Pharmacology, Huazhong University of Science and Technology
- Sep. 1998 - July 2002 - BSc in Veterinary Medicine, Huazhong Agricultural University, China